Stock listing
NASDAQ:DXR Daxor Corporation Stock
Home listing (NASDAQ) of Daxor Corporation
Follow Daxor Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:DXR
$7.45 USD -0.56 (-7.0%)
Close on Nov 20, 2026
- Day range
- $7.00 – $7.88 USDNov 20, 2026
- Volume
- 33,829 sharesNov 20, 2026
- Market cap
- $43.49M USDAt the close on Nov 20, 2026 · price × 5.84M shares outstanding
- 52-week range
- $7.00 – $14.76 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $234,281 USDMedian day 13,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DXR · Home | $7.45 USD | -0.56 (-7.0%) | 33,829 | $7.82 | $7.88 | $7.00 | $8.01 | Close on Nov 20, 2026 |
| Frankfurt:DX5 | €6.90 EUR | +0.30 (+4.5%) | — | €6.90 | €6.90 | €6.90 | €6.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:DXR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.45 | -0.56 | -7.0% | $7.82 | $7.88 | $7.00 | 33,829 | |
| $8.01 | -0.085 | -1.1% | $7.90 | $8.04 | $7.90 | 8,294 | |
| $8.095 | -0.26 | -3.1% | $8.20 | $8.20 | $8.095 | 5,150 | |
| $8.355 | -0.125 | -1.5% | $8.50 | $8.50 | $8.355 | 1,907 | |
| $8.48 | +0.02 | +0.2% | $8.49 | $8.55 | $8.35 | 16,687 | |
| $8.46 | -0.06 | -0.7% | $8.56 | $8.56 | $8.24 | 5,709 | |
| $8.52 | -0.01 | -0.1% | $8.62 | $8.623 | $8.49 | 3,565 | |
| $8.53 | -0.19 | -2.2% | $8.64 | $8.725 | $8.51 | 6,037 | |
| $8.72 | +0.27 | +3.2% | $8.60 | $8.72 | $8.40 | 6,781 | |
| $8.45 | -0.18 | -2.1% | $8.75 | $8.75 | $8.42 | 8,178 | |
| $8.63 | -0.282 | -3.2% | $8.49 | $8.83 | $8.48 | 29,367 | |
| $8.913 | +0.213 | +2.4% | $8.65 | $9.14 | $8.65 | 10,580 | |
| $8.70 | -0.30 | -3.3% | $8.89 | $8.95 | $8.50 | 36,111 | |
| $9.00 | -0.20 | -2.2% | $9.19 | $9.19 | $8.90 | 3,683 | |
| $9.20 | +0.28 | +3.1% | $8.86 | $9.20 | $8.40 | 27,883 | |
| $8.92 | -0.05 | -0.6% | $8.84 | $8.98 | $8.84 | 3,667 | |
| $8.97 | +0.08 | +0.9% | $8.91 | $9.05 | $8.85 | 16,185 | |
| $8.89 | -0.32 | -3.5% | $8.87 | $9.20 | $8.77 | 8,160 | |
| $9.21 | -0.04 | -0.4% | $9.00 | $9.23 | $9.00 | 9,601 | |
| $9.25 | -0.15 | -1.6% | $9.68 | $9.68 | $9.24 | 21,100 | |
| $9.40 | -0.37 | -3.8% | $9.86 | $9.86 | $9.34 | 15,300 | |
| $9.77 | +0.02 | +0.2% | $9.61 | $9.77 | $9.60 | 11,300 | |
| $9.75 | -0.09 | -0.9% | $10.04 | $10.04 | $9.70 | 2,800 | |
| $9.84 | -0.21 | -2.1% | $10.12 | $10.12 | $9.68 | 7,900 | |
| $10.05 | -0.15 | -1.5% | $10.20 | $10.28 | $10.05 | 4,500 | |
| $10.20 | +0.11 | +1.1% | $10.36 | $10.36 | $10.08 | 24,400 | |
| $10.09 | -0.26 | -2.5% | $10.50 | $10.50 | $9.95 | 15,500 | |
| $10.35 | +0.05 | +0.5% | $10.36 | $10.58 | $10.07 | 19,600 | |
| $10.30 | -0.11 | -1.1% | $10.49 | $10.49 | $10.21 | 4,800 | |
| $10.41 | -0.05 | -0.5% | $10.51 | $10.71 | $10.41 | 7,500 | |
| $10.46 | -0.05 | -0.5% | $10.67 | $10.67 | $10.36 | 3,500 | |
| $10.51 | +0.21 | +2.0% | $10.41 | $10.78 | $10.02 | 7,400 | |
| $10.30 | -0.33 | -3.1% | $10.43 | $10.43 | $10.30 | 2,900 | |
| $10.63 | +0.01 | +0.1% | $10.60 | $11.07 | $10.50 | 30,300 | |
| $10.62 | -0.36 | -3.3% | $10.72 | $10.79 | $10.50 | 8,200 | |
| $10.98 | -0.27 | -2.4% | $11.18 | $11.35 | $10.55 | 16,100 | |
| $11.25 | -0.45 | -3.8% | $11.70 | $11.77 | $10.99 | 30,000 | |
| $11.70 | +0.35 | +3.1% | $10.79 | $11.86 | $10.79 | 34,300 | |
| $11.35 | +0.34 | +3.1% | $10.80 | $11.59 | $10.44 | 11,700 | |
| $11.01 | -0.38 | -3.3% | $11.41 | $11.41 | $10.46 | 16,400 | |
| $11.39 | +0.57 | +5.3% | $10.96 | $11.61 | $10.63 | 26,800 | |
| $10.82 | -0.41 | -3.7% | $11.15 | $11.15 | $10.62 | 11,400 | |
| $11.23 | +0.05 | +0.4% | $10.95 | $11.50 | $10.90 | 21,100 | |
| $11.18 | -0.27 | -2.4% | $11.20 | $11.61 | $11.00 | 18,100 | |
| $11.45 | -0.18 | -1.5% | $11.10 | $11.80 | $11.05 | 26,900 | |
| $11.63 | -0.09 | -0.8% | $11.94 | $11.94 | $11.49 | 31,100 | |
| $11.72 | +0.57 | +5.1% | $11.44 | $12.25 | $11.34 | 201,100 | |
| $11.15 | -0.12 | -1.1% | $11.40 | $11.53 | $10.99 | 15,800 | |
| $11.27 | -0.20 | -1.7% | $11.34 | $12.07 | $10.56 | 200,700 | |
| $11.47 | +0.63 | +5.8% | $10.89 | $11.47 | $10.27 | 69,800 | |
| $10.84 | -0.01 | -0.1% | $11.09 | $11.24 | $10.43 | 71,300 | |
| $10.85 | +0.39 | +3.7% | $10.58 | $11.12 | $10.58 | 15,000 | |
| $10.46 | +0.19 | +1.9% | $9.90 | $10.70 | $9.90 | 47,700 | |
| $10.27 | -0.28 | -2.7% | $10.24 | $10.65 | $10.15 | 6,800 | |
| $10.55 | -0.19 | -1.8% | $10.58 | $11.11 | $10.00 | 51,600 | |
| $10.74 | -0.16 | -1.5% | $10.30 | $10.89 | $10.08 | 25,800 | |
| $10.90 | +0.82 | +8.1% | $10.50 | $11.00 | $9.95 | 24,400 | |
| $10.08 | -0.12 | -1.2% | $9.90 | $10.08 | $9.90 | 900 | |
| $10.20 | +0.53 | +5.5% | $9.67 | $10.62 | $9.65 | 13,300 | |
| $9.67 | -0.36 | -3.6% | $9.95 | $10.21 | $9.60 | 13,500 | |
| $10.03 | +0.03 | +0.3% | $10.00 | $10.03 | $9.55 | 1,000 | |
| $10.00 | 0.00 | 0.0% | $10.02 | $10.02 | $9.76 | 1,082 | |
| $10.00 | 0.00 | 0.0% | $9.97 | $10.15 | $9.95 | 276 | |
| $10.00 | -0.30 | -2.9% | $9.97 | $10.15 | $9.95 | 2,000 | |
| $10.30 | 0.00 | 0.0% | $10.30 | $10.30 | $10.30 | 25 |
- Ticker
- NASDAQ:DXR
- Asset type
- Fund
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 18, 2026
Major Memphis Health System Expands BVA® Adoption to New Hospital Outpatient Site
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 37 slides
Latest news
Major Memphis Health System Expands BVA® Adoption to New Hospital Outpatient Site
Nov 18, 2026
Closed $8.01 (-1.1%) on Nov 18, 2026
Daxor Expands Midwest Footprint with Launch of ezBVA Lab Program at Premier Kansas Academic Medical Center
Nov 17, 2026
Closed $8.10 (-3.1%) on Nov 17, 2026
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
Oct 15, 2026
Closed $10.20 (+1.1%) on Oct 15, 2026
Daxor Corporation on 6ix
- What it is
- Closed-end fund
- News releases
- 3 in the last 12 months · 3 in all · newest Nov 18, 2026 · oldest 2026
- Calls
- 3 calls with a replay · 3 with a transcript · latest Mar 6, 2025
- Decks
- 8 decks · latest March 2026
Where Daxor Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DXR · Home listing · This page | NASDAQ | United States | USD |
| Frankfurt:DX5 | Frankfurt | Germany | EUR |
Events
Calls
| Call | When | Status |
|---|---|---|
| Daxor (NASDAQ:DXR) Q4 2024 Earnings Call | Thu, Mar 06, 2025 · 4:30 PM ET | Replay |
| Daxor (NASDAQ:DXR) Q4 2023 Earnings Call | Sat, Mar 25, 2023 · 4:30 PM ET | Replay |
| Daxor (NASDAQ:DXR) Q4 2022 Earnings Call | Thu, Mar 02, 2023 · 9:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Jun 30, 2025 | Aug 29, 2025 | −7.6% |
| Quarter to Mar 31, 2025 | May 13, 2025 | +0.6% |
| Quarter to Dec 31, 2024 | Mar 3, 2025 | −0.3% |
| Quarter to Sep 30, 2024 | Nov 29, 2024 | −1.6% |
| Quarter to Jun 30, 2024 | Aug 22, 2024 | −2.0% |
| Quarter to Mar 31, 2024 | May 16, 2024 · After close | +0.5% |
| Quarter to Dec 31, 2023 | Mar 18, 2024 | −1.3% |
| Quarter to Sep 30, 2023 | Nov 9, 2023 | −0.3% |
| Quarter to Jun 30, 2023 | Aug 28, 2023 · After close | +3.2% |
| Quarter to Mar 31, 2023 | May 9, 2023 | +2.2% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2022 | Mar 1, 2023 · After close | +5.5% |
| Quarter to Sep 30, 2022 | Nov 10, 2022 | −10.1% |
| Quarter to Jun 30, 2022 | Aug 25, 2022 · After close | −8.6% |
| Quarter to Mar 31, 2022 | May 15, 2022 · After close | +0.5% |
| Quarter to Dec 31, 2021 | Feb 15, 2022 · After close | 0.0% |
| Quarter to Sep 30, 2021 | Nov 15, 2021 · After close | +2.3% |
| Quarter to Jun 30, 2021 | Aug 15, 2021 · After close | −2.0% |
| Quarter to Mar 31, 2021 | May 15, 2021 · After close | −6.2% |
| Quarter to Dec 31, 2020 | Feb 15, 2021 · After close | −1.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2026) | Investor deck | 37 slides | March 2026 |
| Investor Presentation (January 2026) | Investor deck | 37 slides | Jan 23, 2026 |
| Investor Presentation (September 2024) | Investor deck | 40 slides | September 2024 |
| Investor Presentation (April 2024) | Investor deck | 45 slides | April 2024 |
| Investor Presentation (November 2023) | Investor deck | 44 slides | November 2023 |
| Investor Presentation (September 2023) | Investor deck | 44 slides | September 2023 |
| Investor Presentation (May 2023) | Investor deck | 42 slides | May 2023 |
| H.C. Wainwright 24th Annual Global Investment Conference 2022 | Conference | 41 slides | September 2022 |
Cap table
Built by 6ix from Daxor Corporation’s releases
- Common shares
- 5,838,224
- Fully diluted
- 5,838,224
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,838,224 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,838,224 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert J. Michel Other companies: BIO-key International, Inc. (Board Member · Since at least Apr 10, 2017); Asta Funding Inc (Chief Financial Officer · Feb 20, 2009 – Feb 14, 2014 · Past) | Chief Financial Officer · Since at least Sep 28, 2018 |
| Bernhard Saxe | Director · Jun 25, 2020 – Jun 25, 2020 · Past |
| Caleb DesRosiers | Director · Since at least Jan 18, 2022 |
| Everis Engstrom | Vice President · Dec 4, 2008 – Dec 4, 2008 · Past |
| Henry D Cremisi | Director · Since at least Jun 23, 2022 |
| James A Lombard | Director · Jun 25, 2020 – Jul 11, 2023 · Past |
| Jonathan Adam Feldschuh | Chief Scientific Officer, Director · Since at least Dec 9, 2025 |
| Joy S Goudie | Director · Since at least Jun 29, 2020 |
| Michael Richard Feldschuh | Chief Executive Officer, Director · Since at least Oct 7, 2013 |
| Philip Nordan Hudson | Director · Jun 23, 2010 – Mar 28, 2012 · Past |
Log in to ask 6ix AI your own questions about Daxor Corporation.